Factorial Energy FAC 深 沪
已收盘 10-09 16:00:00 美东时间
5.14
+0.060
+1.18%
华盛通- 最 高5.2899
- 今 开5.10
- 成交量 13.02万股
- 最 低 5.01
- 昨 收 5.08
- 总市值 5.50亿
- 52周最高 25.33
- 市盈率 静 28.51
- 换手率 0.12%
- 52周最低 0.814
- 委 比 44.29%
- 总股本 1.07亿
- 历史最高 25.33
- 量 比 0.54
- 振 幅 5.51%
- 历史最低 0.78
- 每 手 1
- 风险率 3.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Factorial Energy Faces $4.5 Million Arbitration Setback
The latest update is out from Factorial Energy ( ($FAC) ). Factorial Energy Inc...
10-10 04:59
Factorial Energy shares are trading higher after the company announced a strategic partnership with Mitsui Kinzoku to support the industrialization of its Solstice all-solid-state battery platform.
Factorial Energy shares are trading higher after the company announced a strategic partnership with Mitsui Kinzoku to support the industrialization of its Solstice all-solid-state battery platform.
09-17 22:25
Mitsui Kinzoku Partners with Factorial to Scale All-Solid-State Battery Manufacturing
Factorial Energy partners with Mitsui Kinzoku to advance its all-solid-state battery platform, Solstice™. Mitsui Kinzoku brings foundational solid-state electrolyte technology, while Factorial focuses on cell design and manufacturing. This collaboration aims to accelerate the commercialization of next-generation batteries, addressing industry challenges and driving the energy layer for future mobility and aerospace applications.
09-17 11:00
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 450 points on Tuesday. Shares of Roivant Sciences Ltd (NASDAQ:ROIV) rose sharply during Tuesday’s session after the company shared topline data from its Phase 2 PHocus clinical trial evaluating mosliciguat for pulmonary hypertension ass...
09-08 22:03
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
Oppenheimer Initiates Coverage On Factorial Energy with Outperform Rating, Announces Price Target of $8
Oppenheimer analyst Colin Rusch initiates coverage on Factorial Energy (NASDAQ:FAC) with a Outperform rating and announces Price Target of $8.
08-26 00:10
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
Cantor Fitzgerald Reiterates Overweight on Factorial Energy, Maintains $18 Price Target
Cantor Fitzgerald analyst Derek Soderberg reiterates Factorial Energy (NASDAQ:FAC) with a Overweight and maintains $18 price target.
08-12 18:42
Factorial Energy Q2 EPS $(0.85) Misses $(0.04) Estimate
Factorial Energy (NASDAQ:FAC) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(0.04) by 2025 percent.
08-12 04:29
Factorial Energy Receives First Commercial Drone Battery Order
Factorial Energy Inc. (NASDAQ:FAC) ("Factorial"), a leading American solid-state battery innovator, today announced its first commercial drone battery order. The order marks Factorial’s entry into commercial aerospace applications. The order marks Factorial’s first commercial order in the aerospace ...
07-24 21:26
